Recent experimental research identifies the fecal DPP4 colitis biomarker as a significant indicator of colonic injury. Dipeptidyl peptidase 4 (DPP4) modulates intestinal homeostasis and immune regulation. However, researchers have only recently characterized its distribution during acute intestinal inflammation. Therefore, this study investigated DPP4 concentrations across multiple biological matrices in a TNBS-induced rat model of colitis. Specifically, the team looked at serum, tissue, and fecal levels to understand disease progression.

Key Findings on the Fecal DPP4 Colitis Biomarker

Additionally, the investigators assessed host and microbiota contributions using knockout and germ-free mice. They found that TNBS-induced colitis creates regionally heterogeneous inflammation, especially in the distal colon. Healthy rats typically maintain a proximal-to-distal gradient of colonic DPP4. During inflammation, however, this gradient disappears. Furthermore, fecal DPP4 concentrations increased significantly in the treated animals, reaching their highest levels in collected fecal pellets.

Specifically, the fecal DPP4 colitis biomarker correlated strongly with macroscopic and histological scores. In contrast, serum DPP4 levels showed no significant difference between the groups. This suggests that local shedding into the lumen drives fecal levels rather than systemic changes. Moreover, reduced levels in germ-free mice indicate that host-microbiota crosstalk influences enzyme modulation. Consequently, fecal DPP4 reflects regional and histological features of experimental colitis accurately.

Clinical Implications for Gastrointestinal Health

This non-invasive tool integrates local intestinal injury with luminal shedding. While fecal calprotectin remains the standard, this biomarker may offer additional diagnostic precision in the future. Nevertheless, researchers must conduct human clinical trials to validate these preclinical findings. Understanding the host-microbiota interaction remains crucial for developing targeted therapies. Ultimately, identifying specific markers like DPP4 could enhance personalized management of inflammatory bowel disease.

Frequently Asked Questions

Why is fecal DPP4 considered a potential biomarker for colitis?

It reflects regional colonic injury and histological damage more accurately than serum levels. It increases significantly during inflammation and correlates strongly with disease severity scores.

How does the gut microbiota influence fecal DPP4 levels?

Research using germ-free mice shows that the absence of gut bacteria leads to reduced fecal DPP4 levels. This suggests that interactions between the host's intestinal cells and the microbiota modulate the shedding and concentration of the enzyme.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Gomes SF et al. Fecal DPP4 concentration reflects colonic injury in the TNBS-induced rat model of colitis. Am J Physiol Gastrointest Liver Physiol. 2026 Apr 09. doi: 10.1152/ajpgi.00030.2026. PMID: 41954993.